On May 17th, American Heart Association (AHA) and American Stroke Association (ASA) jointly published the latest edition of the 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage (ICH), in which the original research findings of Professor LI Qi were cited and recommended to change the current clinical practice. Both AHA and ASA are international academic organizations with high prestige and long history. The AHA/ASA Guideline is the top international clinical practice guideline, which provides recommendations to guide clinicians for treatment of patients with cerebrovascular diseases.
“Ultra-early blood pressure reduction”, a new treatment strategy for ICH, was firstly proposed by Professor Li and demonstrated to improve functional outcome in patients with ICH. Now, professor Li’s Ultra-early blood pressure reduction strategy has been included in three international guidelines, i.e., 2021 European Stroke Organisation Guidelines on Blood Pressure Management in Acute Ischaemic Stroke and Behandlung von spontanen intrazerebralen Blutungen von Deutschen Gesellschaft für Neurologie and 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. It’s noted that several original research findings of professor Li (NCCT markers for prediction of hematoma expansion and intraventricular hemorrhage growth) have been cited and recommended in the 2022 AHA/ASA Guideline for ICH management, which is the 10th clinical practice guideline that included his research findings in the field of ICH.
